Why your favourite clinic’s Instagram looks so restrained
Luxury aesthetics sells a vision long before anyone books a consultation. The polished reception, the quiet treatment rooms, the careful language on a website, all of it signals a certain standard. Social media is part of that world now too. Many readers will have a short list of clinics they follow on Instagram, quietly weighing up where they might feel comfortable walking in.
Look a little more closely though and something is missing. The accounts that feel most trustworthy often show less. Fewer extreme before and afters, fewer graphic procedure videos, more focus on experience and context. In contrast, the most aggressive content, and the most dramatic transformations, often come from clinics that feel slightly off. The tone is different, the claims are less careful, and the camera seems always to be inches from a face.
It can be tempting to read this as a sign of confidence. The louder clinic must surely be more sure of itself. The quieter one perhaps has less to show. In Canada, the reality is almost the opposite. The more established medical aesthetics practices are usually holding back for a very specific reason: Health Canada.
The line between beauty and medicine
Medical aesthetics sits in a complicated place. It is bundled into the beauty industry in magazines and on social media, yet it is governed by healthcare rules when the treatment involves prescription products. Clinics operate in a retail environment, but the tools they use are regulated as drugs or medical devices.
This difference matters online. Health Canada’s position is clear that prescription drugs cannot be advertised directly to the public the way a lipstick or a moisturiser can. Most consumers have a general sense that you do not see glossy television adverts for serious medicines in Canada. That same principle applies to injectable prescription drugs used in aesthetics.
What often surprises people is how precisely regulators have addressed this. Health Canada maintains a guidance page, Illegal marketing of prescription drugs, last modified in August 2020. It is not a niche document. It was written, in part, because Health Canada had found that “the illegal direct-to-consumer advertising of prescription drugs by health care providers and clinics was widespread”.
What Health Canada actually says about Botox
The same guidance names Botox directly, which is unusual for a regulator. Health Canada writes:
“Botox is an example of a prescription drug that health care providers and clinics sometimes market to consumers. No direct or indirect reference can be made to its therapeutic use and/or benefits.”
That sentence sits at the heart of why serious clinics, particularly those led by physicians, appear restrained online. Botox is not the only product affected, but it is the clearest example because its brand name is so widely recognised.
The law is not limited to manufacturers. Health Canada states:
“Anyone who promotes the sale of a specific health product is subject to this legislation. This includes health care providers.”
In other words, a clinic that posts about prescription injectables on Instagram is caught by the same federal rules as the pharmaceutical company that makes the product. The fact that a clinic is small, local and privately owned does not change its obligations.
Health Canada lists a series of “commonly encountered issues” in online marketing by clinics. These include:
“videos describing the procedures” “before and after treatment pictures” * “testimonials regarding the therapeutic benefits”
If a post directly or indirectly ties these to a specific prescription product, Health Canada considers that illegal consumer advertising. That is true even if the brand name only appears in a hashtag, caption or casual reference, and even if the tone of the post is educational rather than salesy.
Why fillers are treated differently
One point that often causes confusion in clinics and in the wider beauty conversation is the status of dermal fillers. In Canada, dermal fillers are regulated as medical devices, not as prescription drugs. The Health Canada guidance on illegal prescription drug marketing does not reach them.
That does not mean fillers are unregulated. Medical devices are subject to their own framework and professional colleges have their own advertising rules. It does mean, however, that the specific federal prohibition on consumer advertising of prescription drugs, and the examples in the 2020 guidance, are not directed at fillers.
This is why a clinic might show relatively free use of filler-related content, while treating Botox and similar prescription injectables with more caution. To a casual viewer, this can look inconsistent, or even like favouring one product over another. In reality it reflects the differing legal treatment of drugs and devices.
The narrow paths clinics can legally use
Canadian law allows only two narrow forms of consumer-facing communication about prescription products.
First, “reminder ads” can mention a product name, price and quantity, but they cannot mention the disease or condition the product treats. This category is more relevant to retail pharmacy than to aesthetics clinics.
Second, “help-seeking” messages can describe a disease or condition and encourage people to consult a healthcare professional, but they cannot name a specific drug.
For an aesthetics clinic this creates a delicate balance. It is permissible to talk about frown lines, to explain in general terms that there are medical treatments available, and to encourage a reader to seek professional advice. It is not permissible to connect that condition to a named prescription product and describe the benefits that product delivers.
This is why the most careful clinics often post in quite general language about facial dynamics, ageing and skin quality, but avoid product names and bold claims. It is also why some of them make a clear distinction between their patient education materials, which might be shared privately, and their public-facing social content.
When your feed is a compliance document
From a distance, luxury aesthetics marketing looks like a styling exercise. In practice, for clinics that wish to stay on the right side of the regulator and their professional colleges, content planning has more in common with compliance work.
Agencies that specialise in the sector are very aware of this. Health Hue Digital, for instance, is a Toronto-based marketing agency and software platform that works with medical aesthetics and healthcare practices. Its team is not made up of clinicians and it does not treat patients, yet it still has to plan campaigns around the legal limits on what its clients can show and say. Its marketing for med spas materials, like those of other specialist firms, sit alongside detailed internal guidance on when to strip out a brand name, when to anonymise a result and when to decline a requested post entirely.
On the clinic side, owners are increasingly treating their Instagram grids and websites as documents that could, in theory, be read by a regulator. That mindset changes creative decisions in quiet ways. A dramatic video of a needle in motion might attract views, but if it is linked directly to a named prescription drug and framed as a promise of benefit, it may fall squarely into the category of content Health Canada has warned about.
Why this restraint is a feature, not a flaw
For consumers used to the unfiltered approach of some international accounts, particularly from jurisdictions with looser rules, Canadian feeds can feel subdued. It is natural to feel more curious about a clinic that shows everything and explains every product in detail.
In the Canadian context though, discretion is often a marker that a clinic takes its obligations seriously. It suggests that someone has read the Health Canada guidance, spoken with their professional college or legal counsel, and made deliberate choices about how to present their work.
There is also a cultural piece. Medical aesthetics is inching further into the mainstream each year, but many patients still expect a level of privacy. They may agree to have photographs taken for their medical file and for the treating practitioner’s own reference, but prefer not to have those images broadcast as marketing content. The stricter clinics tend to honour that preference and rely more on atmosphere, education and professional biography than on graphic transformation shots.
None of this means results are absent behind the scenes. It means that the most visible part of a clinic’s identity is being shaped by quieter factors, including a federal rulebook that takes a notably conservative view of how prescription drugs should be presented to the public.
For a reader scrolling through options, that context can make restrained feeds look different. The lack of before and after images or branded injectable talk is not necessarily a lack of confidence. In many cases, it is simply Canada’s advertising law, written into the grid.
